Time-varying prognostic impact of tumour biological factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancer
- 1 August 1997
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 76 (3) , 306-311
- https://doi.org/10.1038/bjc.1997.383
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancerInternational Journal of Cancer, 1995
- Co‐expression of urokinase, urokinase receptor and PAI‐1 is necessary for optimum invasiveness of cultured lung cancer cellsInternational Journal of Cancer, 1995
- Novel methods for the determination of the angiogenic activity of human tumorsBreast Cancer Research and Treatment, 1995
- Urokinase (uPA) and PAI-1 Predict Survival in Advanced Ovarian Cancer Patients (FIGO III) after Radical Surgery and Platinum-Based ChemotherapyGynecologic Oncology, 1994
- Impact of urokinase-type plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus.1994
- Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasisGastroenterology, 1994
- Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue.1994
- Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer.1994
- Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer.1994
- Urokinase plasminogen activator (uPA) and its type 1 inhibitor (PAI-1): Regulators of proteolysis during cancer invasion and prognostic parameters in Breast cancerPublished by Springer Nature ,1994